Phase I Study of HL-085 in Patients With Advanced Solid Tumors
Condition: Solid Tumor, Adult Intervention: Drug: HL-085 Sponsor: Shanghai Kechow Pharma, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials